Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RSHO Blue Liquid Hemp Oil is a full-spectrum cannabidiol (CBD) dietary supplement developed by HempMeds, a subsidiary of Medical Marijuana, Inc. It is derived from non-GMO hemp (*Cannabis sativa L.*) using a solvent-free CO2 extraction process. The "Blue Label" designation indicates that the raw hemp oil has undergone decarboxylation, a heating process that converts cannabidiolic acid (CBDa) into active CBD, resulting in a higher concentration of CBD compared to the "Green Label" variant. The product is formulated with organic MCT oil as a carrier and contains a variety of cannabinoids, terpenes, vitamins, minerals, and essential fatty acids. It is marketed for general wellness and nutritional support rather than as a pharmaceutical treatment for specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RSHO Blue Liquid Hemp Oil.